Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Ribosomal protein L35a pseudogene (RPL35AP)** is a *processed pseudogene*, meaning it is a genomic sequence resembling the functional RPL35A gene but is non-functional and does not encode a protein due to lack of necessary regulatory elements or presence of disabling mutations. RPL35A pseudogenes are common, with several copies scattered across mammalian genomes, a typical feature for ribosomal protein genes[2][6]. These arise from the duplication or retrotransposition of the RPL35A gene. RPL35AP does not have a known biological function or disease association and is not considered a protein, receptor, enzyme, transporter, or therapeutic target[2][4][6]. **Clarification:** - The *pseudogene* form (RPL35AP) is distinct from the functional **RPL35A gene**, which encodes the ribosomal protein L35a needed for ribosome function and is implicated in Diamond-Blackfan anemia[1][3][5][7]. - Pseudogenes such as RPL35AP are generally non-coding and non-functional, thus are not considered drug targets, do not bind drugs, and are not implicated as biomarkers or in therapeutic safety concerns[2][4][6]. **Summary:** RPL35AP refers to a non-functional, non-coding *pseudogene* related to ribosomal protein L35a. It is not a therapeutic or biological target and has no biological, disease, or pharmacological significance[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35a pseudogene (RPL35AP).